An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
The purpose of this study is to evaluate the long-term safety and tolerability of vilazodone for the treatment of MDD in pediatric outpatients (7-17 years).
Inclusion Criteria:
Exclusion Criteria:
Saint Charles, Missouri 63304, United States
Buffalo, New York 14215, United States